ReviewJCO precision oncology2026

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Susanne A Gatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.